• About Us
• In the News
• Contact Us

• For Patients
• For Healthcare Professionals
• For Investors
• Products

• Webcasts
• Investor Presentations
• For Media
• Events
• Press Releases
  • 2012
    • May 8, 2012 Conference Call
    • May 8, 2012
    • May 1, 2012
    • April 24, 2012
    • April 10, 2012
    • March 22, 2012
    • March 16, 2012
    • March 6, 2012 Conference Call
    • March 6, 2012
    • March 7, 2012
    • February 28, 2012
    • February 8, 2012
    • February 6, 2012
  • 2011
  • 2010
  • 2009
  • 2008

2012

May 8, 2012 Conference Call
DUSA Pharmaceuticals Reports First Quarter 2012 Corporate Highlights and Financial Results Conference Call

May 8, 2012
DUSA Pharmaceuticals Reports First Quarter 2012 Corporate Highlights and Financial Results

May 1, 2012
DUSA Pharmaceuticals, Inc.® to Host First Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call

April 24, 2012
DUSA Pharmaceuticals Completes Enrollment in Phase 2 Studies of Levulan® Kerastick® Photodynamic Therapy

April 10, 2012
DUSA Pharmaceuticals Introduces Teeing Off Against Sun Damage™ Campaign to Raise Awareness of Actinic Keratosis

March 22, 2012
DUSA Pharmaceuticals to Present at the 2012 Maxim Group Growth Conference

March 16, 2012
DUSA Pharmaceuticals Introduces "Spot Signs of AK" Campaign to Raise Awareness of a Common Precancerous Skin Condition - Actinic Keratosis

March 6, 2012 Conference Call
DUSA Pharmaceuticals Reports Full Year 2011 Corporate Highlights and Financial Results Conference Call

March 6, 2012
DUSA Pharmaceuticals Reports Full Year 2011 Corporate Highlights and Financial Results

March 7, 2012
DUSA Pharmaceuticals to Present at Roth Capital Partners 24th Annual OC Growth Stock Conference

• For Investors
• For Patients
• For Healthcare Professionals
• Products
• About Us
• In the News
• Contact Us

• Reimbursement / Insurance Support
• Careers
• Legal Notice/Privacy Policy

© 2012, DUSA Pharmaceuticals, Inc.® All Rights Reserved.